NCT04914221View on ClinicalTrials.gov

The Safety and PK Characteristics of the Co-administration of JLP-2002 and Comparator in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

March 13, 2021

Primary Completion Date

May 26, 2021

Study Completion Date

May 26, 2021

Conditions
Overactive Bladder(OAB)
Interventions
DRUG

JLP-2002

administration of JLP-2002

DRUG

Comparator

administration of comparator

Trial Locations (1)

Unknown

Samsung Medical Center, Seoul

Sponsors
All Listed Sponsors
lead

Jeil Pharmaceutical Co., Ltd.

INDUSTRY